454 related articles for article (PubMed ID: 7159214)
1. Epidemiological investigations in young children's communities concerning the efficiency of prophylactic immunization with inactivated influenza vaccine (I.C. 80) in a preepidemic season.
Măgureanu E; Busuioc C; Ionescu V; Tisu A; Coban V; Stoicescu A; Guguianu E; Calomfirescu N; Bordeianu V; Toma C
Arch Roum Pathol Exp Microbiol; 1982; 41(3):233-8. PubMed ID: 7159214
[No Abstract] [Full Text] [Related]
2. [Vaccinal prevention of influenza in children].
Zykov MP; Vasil'eva RI
Tr Inst Im Pastera; 1982; 58():30-8. PubMed ID: 6764981
[No Abstract] [Full Text] [Related]
3. [Patterns of change in the immunity of those inoculated with an inactivated chromatographic influenza vaccine on an annual basis].
Mukhina LP; Bichurina MA; Rozaeva NR
Tr Inst Im Pastera; 1983; 61():151-5. PubMed ID: 6678508
[No Abstract] [Full Text] [Related]
4. Live attenuated influenza vaccine in children.
Ambrose CS; Walker RE; Connor EM
Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372
[TBL] [Abstract][Full Text] [Related]
5. [Effectiveness of inactivated vaccines against influenza].
Fridman EA; Peradze TV
Tr Inst Im Pastera; 1982; 58():84-94. PubMed ID: 6764983
[No Abstract] [Full Text] [Related]
6. [Protection of the elderly against influenza (a review of the literature)].
Rudenko LG; Zykov MP
Vrach Delo; 1981 Dec; (12):8-11. PubMed ID: 6895807
[No Abstract] [Full Text] [Related]
7. Benefits and risks of live attenuated influenza vaccine in young children.
Oster G; Weycker D; Edelsberg J; Nichol KL; Klein JO; Belshe RB
Am J Manag Care; 2010 Sep; 16(9):e235-44. PubMed ID: 21250400
[TBL] [Abstract][Full Text] [Related]
8. The system of population protection against influenza.
Shadrin AS; Karpukhin GI; Gararinova VM; Ivanova AS; Erophejeva MK; Efremov BV; Ignatjeva GS; Kustikova YuG ; Maksakova VL; Turjeva AV
Z Erkr Atmungsorgane; 1985; 165(2):163-70. PubMed ID: 4082659
[TBL] [Abstract][Full Text] [Related]
9. [Experience in using an absorbed influenza chemical vaccine for the immunization of donors in producing anti-influenzal gamma-globulin].
Egorov PA; Isupov FG; Tuĭmedova RA; Afanas'eva GA; Lobanova AM
Tr Inst Im Pastera; 1976; 47():163-6. PubMed ID: 80045
[No Abstract] [Full Text] [Related]
10. Further researches on live influenza virus vaccines.
De Barbieri A; Crovari P; Cuneo-Crovari P; Giacometti G
Dev Biol Stand; 1977 Jun 1-3; 39():73-6. PubMed ID: 604136
[TBL] [Abstract][Full Text] [Related]
11. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
[TBL] [Abstract][Full Text] [Related]
12. [Pharyngeal viral population in 3- to 6-year-old children before and after influenza immunization using the NIVGRIP vaccine administered orally].
Pârvu C; Petrescu A; Coban V
Virologie; 1986; 37(4):263-7. PubMed ID: 3548031
[TBL] [Abstract][Full Text] [Related]
13. Update on influenza activity worldwide and World Health Organization and United States recommendations for influenza vaccine composition for the 1987-1988 season.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1987 Apr; 36(13):193-5. PubMed ID: 3104754
[No Abstract] [Full Text] [Related]
14. [1st experience with human inoculations with an inactivated influenza vaccine].
Beliakov VD; Ivanov KG; Bundzen NG; Tentser PS; Maliarenko IuD
Tr Inst Im Pastera; 1976; 47():114-21. PubMed ID: 802563
[No Abstract] [Full Text] [Related]
15. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
[TBL] [Abstract][Full Text] [Related]
16. Influenza A infections in young children. Primary natural infection and protective efficacy of live-vaccine-induced or naturally acquired immunity.
Wright PF; Ross KB; Thompson J; Karzon DT
N Engl J Med; 1977 Apr; 296(15):829-34. PubMed ID: 846492
[TBL] [Abstract][Full Text] [Related]
17. Influenza vaccine 2007-2008.
Med Lett Drugs Ther; 2007 Oct; 49(1271):81-3. PubMed ID: 17912142
[No Abstract] [Full Text] [Related]
18. [An immunogenicity and reactogenicity study of a purified, inactivated trivalent influenza vaccine for parenteral administration prepared for the 1996-1997 season].
Lupulescu E; Ioniţă E; Botez D; Matepciuc M; Tabra ME; Tecu C; Alexandrescu V; Munţiu A
Bacteriol Virusol Parazitol Epidemiol; 1997; 42(1-2):110-2. PubMed ID: 9235136
[No Abstract] [Full Text] [Related]
19. Statement on influenza vaccination for the 2007-2008 season. An Advisory Committee Statement (ACS).
National Advisory Committee on Immunization (NACI)
Can Commun Dis Rep; 2007 Jul; 33(ACS-7):1-38. PubMed ID: 17663034
[No Abstract] [Full Text] [Related]
20. [Prophylactic effectiveness of an inactivated formol influenza vaccine].
Agafonov VI; Perepelkin VS; Chemeris EA; Novikov NL
Voen Med Zh; 1981 Feb; (2):36-8. PubMed ID: 7233843
[No Abstract] [Full Text] [Related]
[Next] [New Search]
